CORIMUNO-19 – Tocilizumab Trial – TOCI (CORIMUNO-TOCI)
Condition(s):Corona Virus InfectionLast Updated:April 28, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Corona Virus InfectionLast Updated:April 28, 2020Unknown status
Condition(s):SARS-CoV-2; COVID19Last Updated:April 27, 2020Unknown status
Condition(s):Coronavirus Infection; SARS (Severe Acute Respiratory Syndrome); Virus Diseases; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Respiratory Tract Infections; Respiratory Tract DiseaseLast Updated:June 8, 2022Completed
Condition(s):Corona Virus InfectionLast Updated:April 15, 2020Unknown status
Condition(s):COVID19; SARS-CoV-2 InfectionLast Updated:May 6, 2020Suspended
Condition(s):Prostate CancerLast Updated:April 23, 2021Recruiting
Condition(s):Food Allergy; Adherence, MedicationLast Updated:March 25, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.